Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Hypertension. 2019 Jun;73(6):1258–1265. doi: 10.1161/HYPERTENSIONAHA.119.12705

Figure 2: Flow Cytometry and Western Blot Analysis of the Effects of Exogenously 8-Br-cAMP and 8-Br-cGMP Treatment on D1R and AT2R Recruitment.

Figure 2:

8-Br-cAMP (1 mmol/L, 30 min) or 8-Br-cGMP (1 mmol/L, 30 min) significantly increases cell surface D1R (A) and AT2R (B) in human RPTCs measured by flow cytometry. *P<0.05 vs. VEH. 8-Br-cAMP or 8-Br-cGMP also significantly increases cell surface D1R (C) and AT2R (D) measured by Western blot analysis. All blots are normalized to β-actin and then to VEH. *P<0.05 vs. VEH.